Bioventus Inc. (BVS) Misses Q1 EPS by 11c

Bioventus Inc. (NASDAQ: BVS) reported Q1 EPS of ($0.26), $0.11 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $119.06 million versus the consensus estimate of $116.58 million.

For earnings history and earnings-related data on Bioventus Inc. (BVS) click here.

You May Also Be Interested In

• FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• BofA lists top 5 themes driving next $1tn in incremental semi sales